Value in HealthVolume 19, Issue 7, November 2016, Page A469PHP168 - Early Market Access for Pharmaceuticals in EU: What is the Impact of Ema’s Accelerated Assessment Procedure?Author links open overlay panelParviainen L ⁎ 1, Belgaied W 2, Sediri Y 2, Haijeji B 2, Rémuzat C 3, Toumi M 4Show moreShareCitehttps://doi.org/10.1016/j.jval.2016.09.710Get rights and contentUnder an Elsevier user licenseopen archivePrevious article in issueNext article in issueRecommended articlesCited by (0)Copyright © 2016 Published by Elsevier Inc.